Xeris Biopharma Holdings, Inc.
XERS—
Xeris Biopharma Holdings, Inc.XERS$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$0.00
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$291.85M
Net income
$554,000
Net margin
0.2%
Gross margin
6.8%
Dividends & financials
Xeris Biopharma Holdings, Inc. (XERS) reported revenue of $291.85M and net income of $554,000, or $0.00 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.